{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:33:00Z","timestamp":1788784380287,"version":"build-2803163510"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11916-025-01378-z","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T09:50:32Z","timestamp":1742291432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Current Status and Future Prospects of Intra-articular Injection Therapy for Hip Osteoarthritis: A Review"],"prefix":"10.1007","volume":"29","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"10","key":"1378_CR1","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1111\/imj.15933","volume":"53","author":"IN Ackerman","year":"2023","unstructured":"Ackerman IN, Buchbinder R, March L. Global Burden of Disease Study 2019: An opportunity to understand the growing prevalence and impact of hip, knee, hand and other osteoarthritis in Australia. Intern Med J. 2023;53(10):1875\u201382.","journal-title":"Intern Med J."},{"issue":"8","key":"1378_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","volume":"23","author":"VB Kraus","year":"2015","unstructured":"Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage. 2015;23(8):1233\u201341.","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"1378_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2474-8-79","volume":"8","author":"T Rosemann","year":"2007","unstructured":"Rosemann T, Laux G, Kuehlein T. Osteoarthritis and functional disability: results of a cross sectional study among primary care patients in Germany. BMC Musculoskelet Disord. 2007;8(8):79.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"1378_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.joca.2021.04.020","volume":"30","author":"KD Allen","year":"2022","unstructured":"Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 2022;30(2):184\u201395.","journal-title":"Osteoarthritis Cartilage"},{"key":"1378_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/950192","volume":"2012","author":"T H\u00fcgle","year":"2012","unstructured":"H\u00fcgle T, Geurts J, N\u00fcesch C, M\u00fcller-Gerbl M, Valderrabano V. Aging and osteoarthritis: an inevitable encounter? J Aging Res. 2012;2012: 950192.","journal-title":"J Aging Res"},{"issue":"14","key":"1378_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMcp071112","volume":"357","author":"NE Lane","year":"2007","unstructured":"Lane NE. Clinical practice. Osteoarthritis of the hip. N Engl J Med. 2007;357(14):1413\u201321.","journal-title":"N Engl J Med."},{"issue":"1","key":"1378_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMcp1903768","volume":"384","author":"L Sharma","year":"2021","unstructured":"Sharma L. Osteoarthritis of the Knee. N Engl J Med. 2021;384(1):51\u20139.","journal-title":"N Engl J Med"},{"key":"1378_CR8","first-page":"17","volume":"22","author":"J Michelle","year":"2018","unstructured":"Michelle J. Lespasio, Assem A Sultan, Nicolas S Piuzzi, Anton Khlopas, M Elaine Husni, George F Muschler, Michael A Mont. Hip Osteoarthritis: A Primer Perm J. 2018;22:17\u2013084.","journal-title":"Hip Osteoarthritis: A Primer Perm J"},{"issue":"3","key":"1378_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cger.2010.04.001","volume":"26","author":"CM McDonough","year":"2010","unstructured":"McDonough CM, Jette AM. The contribution of osteoarthritis to functional limitations and disability. Clin Geriatr Med. 2010;26(3):387\u201399.","journal-title":"Clin Geriatr Med."},{"issue":"1","key":"1378_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.berh.2006.08.013","volume":"21","author":"JWJ Bijlsma","year":"2007","unstructured":"Bijlsma JWJ, Knahr K. Strategies for the prevention and management of osteoarthritis of the hip and knee. Best Pract Res Clin Rheumatol. 2007;21(1):59\u201376.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10090","key":"1378_CR11","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","volume":"390","author":"BR da Costa","year":"2017","unstructured":"da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, J\u00fcni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390(10090):e21\u201333.","journal-title":"Lancet."},{"issue":"6","key":"1378_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.semarthrit.2013.11.012","volume":"43","author":"AE Nelson","year":"2014","unstructured":"Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM. A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin Arthritis Rheum. 2014;43(6):701\u201312.","journal-title":"Semin Arthritis Rheum."},{"issue":"11","key":"1378_CR13","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578\u201389.","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"1378_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jama.2020.22171","volume":"325","author":"JN Katz","year":"2021","unstructured":"Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021;325(6):568\u201378.","journal-title":"JAMA."},{"key":"1378_CR15","doi-asserted-by":"publisher","first-page":"480291","DOI":"10.5402\/2011\/480291","volume":"2011","author":"ST Mathew","year":"2011","unstructured":"Mathew ST, Gayathri Devi S, Prasanth VV, Vinod B. Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review. ISRN Pharmacol. 2011;2011:480291.","journal-title":"ISRN Pharmacol."},{"issue":"4 Suppl","key":"1378_CR16","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","volume":"45","author":"F Rannou","year":"2016","unstructured":"Rannou F, Pelletier J-P, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S18-21.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1378_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.joca.2019.01.007","volume":"27","author":"C Zeng","year":"2019","unstructured":"Zeng C, Lane NE, Hunter DJ, Wei J, Choi HK, McAlindon TE, Li H, Lu N, Lei G, Zhang Y. Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2019;27(6):855\u201362.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"1378_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.artd.2017.12.002","volume":"4","author":"SR Hess","year":"2018","unstructured":"Hess SR, O\u2019Connell RS, Bednarz CP, Waligora AC 4th, Golladay GJ, Jiranek WA. Association of rapidly destructive osteoarthritis of the hip with intra-articular steroid injections. Arthroplast Today. 2018;4(2):205\u20139.","journal-title":"Arthroplast Today."},{"issue":"2","key":"1378_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41584-018-0123-4","volume":"15","author":"IA Jones","year":"2019","unstructured":"Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019;15(2):77\u201390.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1378_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14728214.2018.1547706","volume":"23","author":"WM Oo","year":"2018","unstructured":"Oo WM, Yu SPC, Daniel MS, Hunter DJ. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics. Expert Opin Emerg Drugs. 2018;23(4):331\u201347.","journal-title":"Expert Opin Emerg Drugs."},{"issue":"10","key":"1378_CR21","first-page":"CD005328","volume":"2015","author":"P J\u00fcni","year":"2015","unstructured":"J\u00fcni P, Hari R, Rutjes AWS, Fischer R, Silletta MG, Reichenbach S, da Costa BR. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015;2015(10):CD005328.","journal-title":"Cochrane Database Syst Rev."},{"issue":"9","key":"1378_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.joca.2007.06.014","volume":"15","author":"W Zhang","year":"2007","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15(9):981\u20131000.","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"1378_CR23","first-page":"2265","volume":"31","author":"B Kullenberg","year":"2004","unstructured":"Kullenberg B, Runesson R, Tuvhag R, Olsson C, Resch S. Intraarticular corticosteroid injection: pain relief in osteoarthritis of the hip? J Rheumatol. 2004;31(11):2265\u20138.","journal-title":"J Rheumatol"},{"issue":"5","key":"1378_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.arthro.2018.02.022","volume":"34","author":"DM Levy","year":"2018","unstructured":"Levy DM, Petersen KA, Vaught MS, Christian DR, Cole BJ. Injections for Knee Osteoarthritis: Corticosteroids, Viscosupplementation, Platelet-Rich Plasma, and Autologous Stem Cells. Arthroscopy. 2018;34(5):1730\u201343.","journal-title":"Arthroscopy."},{"issue":"4","key":"1378_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2165\/00003495-199652040-00004","volume":"52","author":"JR Caldwell","year":"1996","unstructured":"Caldwell JR. Intra-articular corticosteroids. Guide to selection and indications for use. Drugs. 1996;52(4):507\u201314.","journal-title":"Drugs."},{"issue":"12","key":"1378_CR26","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/17425255.2019.1691997","volume":"15","author":"WM Oo","year":"2019","unstructured":"Oo WM, Liu X, Hunter DJ. Pharmacodynamics, efficacy, safety and administration of intra-articular therapies for knee osteoarthritis. Expert Opin Drug Metab Toxicol. 2019;15(12):1021\u201332.","journal-title":"Expert Opin Drug Metab Toxicol."},{"issue":"2","key":"1378_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s40744-022-00430-3","volume":"9","author":"A Kivitz","year":"2022","unstructured":"Kivitz A, Mehra P, Hanson P, Kwong L, Cinar A, Lufkin J, et al. A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis. Rheumatol Ther. 2022;9(2):679\u201391.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"1378_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1590\/1413-785220172505172581","volume":"25","author":"AF Buyuk","year":"2017","unstructured":"Buyuk AF, Kilinc E, Camurcu IY, Camur S, Ucpunar H, Kara A. Compared efficacy of intra-articular injection of methylpredniso lone and triamcinolone. Acta Ortop Bras. 2017;25(5):206\u20138.","journal-title":"Acta Ortop Bras."},{"issue":"1","key":"1378_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.joca.2013.10.009","volume":"22","author":"R Leighton","year":"2014","unstructured":"Leighton R, Akermark C, Therrien R, Richardson JB, Andersson M, Todman MG, et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage. 2014;22(1):17\u201325.","journal-title":"Osteoarthritis Cartilage."},{"issue":"1","key":"1378_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/112070000701700107","volume":"17","author":"SV Karuppiah","year":"2007","unstructured":"Karuppiah SV, Gibson P. The safety of hip injection with corticosteroid in the diagnosis and treatment of osteoarthritis. Hip Int. 2007;17(1):36\u20139.","journal-title":"Hip Int"},{"issue":"6","key":"1378_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/annrheumdis-2017-212628","volume":"77","author":"DMJ Dorleijn","year":"2018","unstructured":"Dorleijn DMJ, Luijsterburg PAJ, Reijman M, Kloppenburg M, Verhaar JAN, Bindels PJE, et al. Intramuscular glucocorticoid injection versus placebo injection in hip osteoarthritis: a 12-week blinded randomised controlled trial. Ann Rheum Dis. 2018;77(6):875\u201382.","journal-title":"Ann Rheum Dis."},{"issue":"20","key":"1378_CR32","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.3390\/jcm12206600","volume":"12","author":"G Ronconi","year":"2023","unstructured":"Ronconi G, Codazza S, Panunzio M, La Cagnina F, Ariani M, Gatto DM, et al. The Effects of Ultrasound-Guided Intra-Articular Injections with Hyaluronic Acid and Corticosteroids in Patients with Hip Osteoarthritis: A Long-Term Real-World Analysis. J Clin Med. 2023;12(20):6600.","journal-title":"J Clin Med."},{"issue":"24","key":"1378_CR33","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1001\/jama.2016.17565","volume":"316","author":"BR da Costa","year":"2016","unstructured":"da Costa BR, Hari R, J\u00fcni P. Intra-articular Corticosteroids for Osteoarthritis of the Knee. JAMA. 2016;316(24):2671\u20132.","journal-title":"JAMA."},{"issue":"23","key":"1378_CR34","first-page":"4985","volume":"20","author":"M Suntiparpluacha","year":"2016","unstructured":"Suntiparpluacha M, Tammachote N, Tammachote R. Triamcinoloneacetonide reduces viability, induces oxidative stress, and alters gene expressions of human chondrocytes. Eur Rev Med Pharmacol Sci. 2016;20(23):4985\u201392.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"1378_CR35","doi-asserted-by":"publisher","first-page":"232596711558116","DOI":"10.1177\/2325967115581163","volume":"3","author":"C Wernecke","year":"2015","unstructured":"Wernecke C, Braun HJ, Dragoo JL. The effect of intra-articular corticosteroids on articular cartilage: a systematic review. Orthop J Sports Med. 2015;3(5):2325967115581163.","journal-title":"Orthop J Sports Med"},{"issue":"8","key":"1378_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1759720X17712695","volume":"9","author":"P Wehling","year":"2017","unstructured":"Wehling P, Evans C, Wehling J, et al. Effectiveness of intra-articular therapies in osteoarthritis: a literature review. Ther Adv Musculoskelet Dis. 2017;9(8):183\u201396.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1378_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1471-2474-11-264","volume":"11","author":"S Colen","year":"2010","unstructured":"Colen S, van den Bekerom MPJ, Bellemans J, Mulier M. Comparison of intra-articular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors. BMC Musculoskelet Disord. 2010;11:264.","journal-title":"BMC Musculoskelet Disord."},{"issue":"1","key":"1378_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/ard.2009.127183","volume":"70","author":"I Atchia","year":"2011","unstructured":"Atchia I, Kane D, Reed MR, Isaacs JD, Birrell F. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis. 2011;70(1):110\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1378_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1471-2474-12-280","volume":"12","author":"DMJ Dorleijn","year":"2011","unstructured":"Dorleijn DMJ, Luijsterburg PAJ, Reijman M, Kloppenburg M, Verhaar JAN, Bindels PJE, et al. Effectiveness of intramuscular corticosteroid injection versus placebo injection in patients with hip osteoarthritis: design of a randomized double-blinded controlled trial. BMC Musculoskelet Disord. 2011;12:280.","journal-title":"BMC Musculoskelet Disord."},{"issue":"1","key":"1378_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.crad.2011.07.040","volume":"67","author":"R Young","year":"2012","unstructured":"Young R, Harding J, Kingsly A, Bradley M. Therapeutic hip injections: is the injection volume important? Clin Radiol. 2012;67(1):55\u201360.","journal-title":"Clin Radiol"},{"issue":"7","key":"1378_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.5811\/westjem.2014.9.20575","volume":"15","author":"ES Anderson","year":"2014","unstructured":"Anderson ES, Hodell E, Mantuani D, Fahimi J, Pampalone I, Nagdev A. Pilot study of ultrasound-guided corticosteroid hip injections by emerg- ency physicians. West J Emerg Med. 2014;15(7):919\u201324.","journal-title":"West J Emerg Med."},{"issue":"1","key":"1378_CR42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12891-018-2153-0","volume":"19","author":"Z Paskins","year":"2018","unstructured":"Paskins Z, Hughes G, Myers H, Hughes E, Hennings S, Cherrington A, et al. A randomised controlled trial of the clinical and cost-effectiveness of ultrasound-guided intra-articular corticosteroid and local anaesthetic injections: the hip injection trial (HIT) protocol. BMC Musculoskelet Disord. 2018;19(1):218.","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"1378_CR43","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00256-021-03815-7","volume":"50","author":"RD Boutin","year":"2021","unstructured":"Boutin RD, Pai J, Meehan JP, Newman JS, Yao L. Rapidly progressive idiopathic arthritis of the hip: incidence and risk factors in a controlled cohort study of 1471 patients after intra-articular corticosteroid injection. Skeletal Radiol. 2021;50(12):2449\u201357.","journal-title":"Skeletal Radiol."},{"key":"1378_CR44","doi-asserted-by":"publisher","first-page":"e068446","DOI":"10.1136\/bmj-2021-068446","volume":"377","author":"Z Paskins","year":"2022","unstructured":"Paskins Z, Bromley K, Lewis M, Hughes G, Hughes E, Hennings S, et al. Clinical effectiveness of one ultrasound guided intra-articular corticoster- oid and local anaesthetic injection in addition to advice and education for hip osteoarthritis (HIT trial): single blind, parallel group, three arm, randomised controlled trial. BMJ. 2022;377:e068446.","journal-title":"BMJ"},{"issue":"9","key":"1378_CR45","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0025-6196(12)62745-1","volume":"65","author":"MG Wilson","year":"1990","unstructured":"Wilson MG, Michet CJ Jr, Ilstrup DM, Melton LJ 3rd. Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence study. Mayo Clin Proc. 1990;65(9):1214\u201321.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"1378_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csm.2013.08.002","volume":"33","author":"JM Bert","year":"2014","unstructured":"Bert JM, Bert TM. Nonoperative treatment of unicompartmental arthritis: from bracing to injection. Clin Sports Med. 2014;33(1):1\u201310.","journal-title":"Clin Sports Med."},{"issue":"6","key":"1378_CR47","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1526-4637.2012.01394.x","volume":"13","author":"OT Cheng","year":"2012","unstructured":"Cheng OT, Souzdalnitski D, Vrooman B, et al. Evidence-based knee injections for the management of arthritis. Pain Med. 2012;13(6):740\u201353.","journal-title":"Pain Med"},{"issue":"12","key":"1378_CR48","doi-asserted-by":"publisher","first-page":"e1501","DOI":"10.3928\/01477447-20131120-13","volume":"36","author":"M Battaglia","year":"2013","unstructured":"Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R, et al. Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics. 2013;36(12):e1501\u20138.","journal-title":"Orthopedics"},{"issue":"11","key":"1378_CR49","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/ard.52.11.817","volume":"52","author":"S Gotoh","year":"1993","unstructured":"Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52(11):817\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1378_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40824-021-00228-4","volume":"25","author":"BM Lee","year":"2021","unstructured":"Lee BM, Park SJ, Noh I, Kim CH. The effects of the molecular weights of hyaluronic acid on the immune responses. Biomater Res. 2021;25(1):27.","journal-title":"Biomater Res."},{"key":"1378_CR51","first-page":"3","volume":"39","author":"EA Balazs","year":"1993","unstructured":"Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3\u20139.","journal-title":"J Rheumatol Suppl"},{"key":"1378_CR52","first-page":"87","volume":"2","author":"AH Conduah","year":"2009","unstructured":"Conduah AH, Baker CL, Baker CL. Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20. J Pain Res. 2009;2:87\u201398.","journal-title":"J Pain Res."},{"issue":"4","key":"1378_CR53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommenda- tions for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465\u201374.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"3","key":"1378_CR54","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363\u201388.","journal-title":"Osteoarthritis Cartilage"},{"key":"1378_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jor.2020.03.016","volume":"21","author":"AJ Acu\u00f1a","year":"2020","unstructured":"Acu\u00f1a AJ, Samuel LT, Jeong SH, Emara AK, Kamath AF. Viscosupplementation for hip osteoarthritis: Does systematic review of patient- reported outcome measures support use? J Orthop. 2020;21:137\u201349.","journal-title":"J Orthop."},{"issue":"5","key":"1378_CR56","first-page":"1303","volume":"32","author":"G Letizia Mauro","year":"2018","unstructured":"Letizia Mauro G, Scaturro D, Sanfilippo A, Benedetti MG. Intra-articular hyaluronic acid injections for hip osteoarthritis. J Biol Regul Homeost Agents. 2018;32(5):1303\u20139.","journal-title":"J Biol Regul Homeost Agents."},{"issue":"2","key":"1378_CR57","doi-asserted-by":"publisher","first-page":"146","DOI":"10.11138\/ccmbm\/2017.14.1.146","volume":"14","author":"GL Mauro","year":"2017","unstructured":"Mauro GL, Sanfilippo A, Scaturro D. The effectiveness of intra-articular injections of Hyalubrix\u00ae combined with exercise therapy in the treatment of hip osteoarthritis. Clin Cases Miner Bone Metab. 2017;14(2):146\u201352.","journal-title":"Clin Cases Miner Bone Metab."},{"key":"1378_CR58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12891-015-0775-z","volume":"16","author":"RD Altman","year":"2015","unstructured":"Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1378_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/sarh.2002.33720","volume":"32","author":"P Ghosh","year":"2002","unstructured":"Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum. 2002;32(1):10\u201337.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1378_CR60","first-page":"1139","volume":"31","author":"M Abate","year":"2017","unstructured":"Abate M, Salini V. Safety and tolerability of intra-articular hyaluronic acid (Sinovial\u00ae\/GELSYN-3tm) injections in the treatment of knee osteoarthritis. J Biol Regul Homeost Agents. 2017;31(4):1139\u201345.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"2","key":"1378_CR61","first-page":"315","volume":"33","author":"SME Ali","year":"2021","unstructured":"Ali SME, Farooqui SF, Sahito B, Ali M, Khan AA, Naeem O. Clinical Outcomes Of Intra-Articular High Molecular Weight Hyaluronic Acid Injection For Hip Osteoarthritis-A Systematic Review And Meta-Analysis. J Ayub Med Coll Abbottabad. 2021;33(2):315\u201321.","journal-title":"J Ayub Med Coll Abbottabad."},{"issue":"23","key":"1378_CR62","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1001\/jama.290.23.3115","volume":"290","author":"GH Lo","year":"2003","unstructured":"Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003;290(23):3115\u201321.","journal-title":"JAMA."},{"issue":"8","key":"1378_CR63","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s10067-022-06154-7","volume":"41","author":"MC Micu","year":"2022","unstructured":"Micu MC, Micu A, Bolboac\u0103 SD. Ultrasound-guided injection with hyaluronic acid in hip osteoarthritis: efficacy and safety in a real-life setting. Clin Rheumatol. 2022;41(8):2491\u20138.","journal-title":"Clin Rheumatol."},{"issue":"1","key":"1378_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/jfmk7010020","volume":"7","author":"D Scaturro","year":"2022","unstructured":"Scaturro D, Vitagliani F, Terrana P, Tomasello S, Falco V, Cuntrera D. Hybrid Hyaluronic Acid versus High Molecular Weight Hyaluronic Acid for the Treatment of Hip Osteoarthritis in Overweight\/Obese Patients. J Funct Morphol Kinesiol. 2022;7(1):20.","journal-title":"J Funct Morphol Kinesiol"},{"key":"1378_CR65","doi-asserted-by":"publisher","first-page":"20210038","DOI":"10.2490\/prm.20210038","volume":"6","author":"G Koyano","year":"2021","unstructured":"Koyano G, Jinno T, Koga D, Hoshino C, Okawa A. Intra-articular Injections of Cross-linked Hyaluronic Acid in Japanese Patients with Symptomatic Osteoarthritis of the Hip. Prog Rehabil Med. 2021;6:20210038.","journal-title":"Prog Rehabil Med"},{"issue":"9","key":"1378_CR66","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3390\/jcm13092515","volume":"13","author":"AG Battaglia","year":"2024","unstructured":"Battaglia AG, D\u2019Apolito R, Labionda F, Ramazzotti J, Zagra L. Ultrasound-Guided Hip Injections with High Density Hyaluronic Acid: Outcome at One Year Follow Up. J Clin Med. 2024;13(9):2515.","journal-title":"J Clin Med."},{"issue":"4","key":"1378_CR67","first-page":"139","volume":"22","author":"C Eyig\u00f6r","year":"2010","unstructured":"Eyig\u00f6r C, Pirim A, Eyig\u00f6r S, Uyar M. Efficacy of intraarticular hyaluronic acid injection through a lateral approach under fluoroscopic control for advanced hip osteoarthritis. Agri. 2010;22(4):139\u201344.","journal-title":"Agri"},{"issue":"7","key":"1378_CR68","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.clinbiomech.2012.02.004","volume":"27","author":"M Paoloni","year":"2012","unstructured":"Paoloni M, Di Sante L, Dimaggio M, Bernetti A, Mangone M, Di Renzo S, et al. Kinematic and kinetic modifications in walking pattern of hip osteoarthritis patients induced by intra-articular injections of hyaluronic acid. Clin Biomech (Bristol, Avon). 2012;27(7):661\u20135.","journal-title":"Clin Biomech (Bristol, Avon)"},{"issue":"4","key":"1378_CR69","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00167-013-2581-1","volume":"22","author":"M Abate","year":"2014","unstructured":"Abate M, Scuccimarra T, Vanni D, Pantalone A, Salini V. Femoroacetabular impingement: is hyaluronic acid effective? Knee Surg Sports Traumatol Arthrosc. 2014;22(4):889\u201392.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"2","key":"1378_CR70","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/039463201402700211","volume":"27","author":"A Migliore","year":"2014","unstructured":"Migliore A, Massafra U, Bizzi E, Tormenta S, Cassol M, Granata M. Duration of symptom relief after intra-articular injection of hyaluronic acid combined with sorbitol (anti-ox-vs) in symptomatic hip osteoarthritis. Int J Immunopathol Pharmacol. 2014;27(2):245\u201352.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"1378_CR71","doi-asserted-by":"publisher","first-page":"463","DOI":"10.11152\/mu-874","volume":"18","author":"L Di Sante","year":"2016","unstructured":"Di Sante L, Villani C, Santilli V, Valeo M, Bologna E, Imparato L, et al. Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis. Med Ultrason. 2016;18(4):463\u20138.","journal-title":"Med Ultrason"},{"issue":"5","key":"1378_CR72","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00590-017-2083-9","volume":"28","author":"D Clementi","year":"2018","unstructured":"Clementi D, D\u2019Ambrosi R, Bertocco P, Bucci MS, Cardile C, Ragni P, et al. Efficacy of a single intra-articular injection of ultra-high molecular weight hyaluronic acid for hip osteoarthritis: a randomized controlled study. Eur J Orthop Surg Traumatol. 2018;28(5):915\u201322.","journal-title":"Eur J Orthop Surg Traumatol."},{"issue":"1","key":"1378_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.joca.2018.08.018","volume":"27","author":"V Brander","year":"2019","unstructured":"Brander V, Skrepnik N, Petrella RJ, Jiang G-L, Accomando B, Vardanyan A. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline. Osteoarthritis Cartilage. 2019;27(1):59\u201370.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"1378_CR74","first-page":"134","volume":"64","author":"MM Villanova-L\u00f3pez","year":"2020","unstructured":"Villanova-L\u00f3pez MM, N\u00fa\u00f1ez-N\u00fa\u00f1ez M, Fern\u00e1ndez-Prieto D, Gonz\u00e1lez-L\u00f3pez C, Garc\u00eda-Donaire J, P\u00e9rez-P\u00e9rez A, et al. Randomized, double-blind, controlled trial, phase III, to evaluate the use of platelet-rich plasma versus hyaluronic acid in hip coxarthrosis. Rev Esp Cir Ortop Traumatol (Engl Ed). 2020;64(2):134\u201342.","journal-title":"Rev Esp Cir Ortop Traumatol (Engl Ed)"},{"issue":"1","key":"1378_CR75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12891-021-04108-9","volume":"22","author":"Y Nishida","year":"2021","unstructured":"Nishida Y, Kano K, Osato T, Seo T. Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-5704 \/SI-613) for treatment of osteoarthritis: 1-year follow-up. BMC Musculoskelet Disord. 2021;22(1):233.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1378_CR76","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12891-022-05328-3","volume":"23","author":"T Kubo","year":"2022","unstructured":"Kubo T, Kumai T, Ikegami H, Kano K, Nishii M, Seo T. Diclofenac-hyaluronate conjugate (diclofenac etalhyaluronate) intra-articul ar injection for hip, ankle, shoulder, and elbow osteoarthritis: a randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):371.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1378_CR77","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1186\/s12891-022-05787-8","volume":"23","author":"F Nouri","year":"2022","unstructured":"Nouri F, Babaee M, Peydayesh P, Esmaily H, Raeissadat SA. Comparison between the effects of ultrasound guided intra-articular injections of platelet-rich plasma (PRP), high molecular weight hyaluronic acid, and their combination in hip osteoarthritis: a randomized clinical trial. BMC Musculoskelet Disord. 2022;23(1):856.","journal-title":"BMC Musculoskelet Disord."},{"key":"1378_CR78","doi-asserted-by":"publisher","first-page":"169S","DOI":"10.1177\/19476035211021903","volume":"13","author":"YZ Wu","year":"2021","unstructured":"Wu YZ, Huang HT, Ho CJ, Shih CL, Chen CH, Cheng TL, et al. Molecular Weight of Hyaluronic Acid Has Major Influence on Its Efficacy and Safety for Viscosupplementation in Hip Osteoarthritis: A Systematic Review and Meta-Analysis. Cartilage. 2021;13:169S-184S.","journal-title":"Cartilage."},{"issue":"3","key":"1378_CR79","first-page":"81","volume":"31","author":"G Gualdi","year":"2019","unstructured":"Gualdi G, Monari P, Cammalleri D, Pelizzari L, Calzavara-Pinton P. Hyaluronic Acid-based Products are Strictly Contraindicated in Scleroderma-related Skin Ulcers. Wounds. 2019;31(3):81\u20134.","journal-title":"Wounds"},{"issue":"1","key":"1378_CR80","doi-asserted-by":"publisher","first-page":"e000071","DOI":"10.1136\/rmdopen-2015-000071","volume":"1","author":"P Richette","year":"2015","unstructured":"Richette P, Chevalier X, Ea HK, Eymard F, Henrotin Y, Ornetti P, et al. Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias. RMD Open. 2015;1(1):e000071.","journal-title":"RMD Open."},{"key":"1378_CR81","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijsu.2017.01.087","volume":"39","author":"W-W He","year":"2017","unstructured":"He W-W, Kuang M-J, Zhao J, Sun L, Bin Lu, Wang Y, et al. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis. Int J Surg. 2017;39:95\u2013103.","journal-title":"Int J Surg"},{"issue":"3","key":"1378_CR82","doi-asserted-by":"publisher","first-page":"232596711983105","DOI":"10.1177\/2325967119831052","volume":"7","author":"DA Houck","year":"2019","unstructured":"Houck DA, Kraeutler MJ, Thornton LB, McCarty EC, Bravman JT. Treatment of Lateral Epicondylitis With Autologous Blood, Platelet-Rich Plasma, or Corticosteroid Injections: A Systematic Review of Overlapping Meta-analyses. Orthop J Sports Med. 2019;7(3):2325967119831052.","journal-title":"Orthop J Sports Med."},{"issue":"1","key":"1378_CR83","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/0363546520909397","volume":"49","author":"JW Belk","year":"2021","unstructured":"Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2021;49(1):249\u201360.","journal-title":"Am J Sports Med."},{"issue":"9","key":"1378_CR84","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00402-020-03551-y","volume":"141","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Driessen A, Quack V, Sippel N, Cooper B, El Mansy Y, et al. Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis. Arch Orthop Trauma Surg. 2021;141(9):1473\u201390.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"8","key":"1378_CR85","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1177\/0363546519881423","volume":"48","author":"X Chen","year":"2020","unstructured":"Chen X, Jones IA, Togashi R, Park C, Vangsness CT Jr. Use of Platelet-Rich Plasma for the Improvement of Pain and Function in Rotator Cuff Tears: A Systematic Review and Meta-analysis with bias assessment. Am J Sports Med. 2020;48(8):2028\u201341.","journal-title":"Am J Sports Med"},{"issue":"6","key":"1378_CR86","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/JSM.0000000000000786","volume":"31","author":"C Maillot","year":"2021","unstructured":"Maillot C, Martellotto A, Demezon H, Harly E, Le Huec J-C. multiple treatment comparisons for large and massive rotator cuff tears: a network meta-analysis. Clin J Sport Med. 2021;31(6):501\u20138.","journal-title":"Clin J Sport Med"},{"key":"1378_CR87","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1097\/PHM.0000000000000115","volume":"93","author":"AM Pourcho","year":"2014","unstructured":"Pourcho AM, Smith J, Wisniewski SJ, Sellon JL. Intraarticular platelet-rich plasma injection in the treatment of knee osteoarthritis: review and recommendations. Am J Phys Med Rehabil. 2014;93:S108-21.","journal-title":"Am J Phys Med Rehabil."},{"issue":"12","key":"1378_CR88","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","volume":"9","author":"I Andia","year":"2013","unstructured":"Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721\u201330.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1378_CR89","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pmrj.2010.11.007","volume":"3","author":"RT Nguyen","year":"2011","unstructured":"Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PMR. 2011;3(3):226\u201350.","journal-title":"PMR."},{"issue":"10","key":"1378_CR90","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s11999-011-1857-3","volume":"469","author":"LA Fortier","year":"2011","unstructured":"Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin Orthop Relat Res. 2011;469(10):2706\u201315.","journal-title":"Clin Orthop Relat Res."},{"issue":"5","key":"1378_CR91","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.joca.2005.10.011","volume":"14","author":"MB Schmidt","year":"2006","unstructured":"Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage. 2006;14(5):403\u201312.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"1378_CR92","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0363546512466383","volume":"41","author":"AS Wasterlain","year":"2013","unstructured":"Wasterlain AS, Braun HJ, Harris AHS, Kim HJ, Dragoo JL. The systemic effects of platelet-rich plasma injection. Am J Sports Med. 2013;41(1):186\u201393.","journal-title":"Am J Sports Med."},{"issue":"11","key":"1378_CR93","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1177\/0363546511419278","volume":"39","author":"GM van Buul","year":"2011","unstructured":"van Buul GM, Koevoet WLM, Nicole Kops P, Bos K, Verhaar JAN, Weinans H, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 2011;39(11):2362\u201370.","journal-title":"Am J Sports Med."},{"issue":"3","key":"1378_CR94","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/JSM.0b013e31827c3846","volume":"23","author":"B Halpern","year":"2013","unstructured":"Halpern B, Chaudhury S, Rodeo SA, Hayter C, Bogner E, Potter HG, et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med. 2013;23(3):238\u20139.","journal-title":"Clin J Sport Med."},{"issue":"2","key":"1378_CR95","doi-asserted-by":"publisher","first-page":"232596711990081","DOI":"10.1177\/2325967119900811","volume":"8","author":"BC Werner","year":"2020","unstructured":"Werner BC, Cancienne JM, Browning R, Verma NN, Cole BJ. An Analysis of Current Treatment Trends in Platelet-Rich Plasma Therapy in the Medicare Database. Orthop J Sports Med. 2020;8(2):2325967119900811.","journal-title":"Orthop J Sports Med."},{"issue":"8","key":"1378_CR96","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1302\/0301-620X.101B8.BJJ-2019-0037.R1","volume":"101-B","author":"LA Rossi","year":"2019","unstructured":"Rossi LA, Murray IR, Chu CR, Muschler GF, Rodeo SA, Piuzzi NS. Classification systems for platelet-rich plasma. Bone Joint J. 2019;101-B(8):891\u20136.","journal-title":"Bone Joint J."},{"issue":"4","key":"1378_CR97","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12178-018-9527-7","volume":"11","author":"ADK Le","year":"2018","unstructured":"Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr Rev Musculoskelet Med. 2018;11(4):624\u201334.","journal-title":"Curr Rev Musculoskelet Med."},{"issue":"1","key":"1378_CR98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0363546513507766","volume":"42","author":"EA Sundman","year":"2014","unstructured":"Sundman EA, Cole BJ, Karas V, Valle CD, Tetreault MW, Mohammed HO, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2014;42(1):35\u201341.","journal-title":"Am J Sports Med."},{"issue":"15","key":"1378_CR99","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.3390\/jcm11154505","volume":"11","author":"A Mazzotta","year":"2022","unstructured":"Mazzotta A, Pennello E, Stagni C, Del Piccolo N, Boffa A, Cenacchi A, et al. Umbilical Cord PRP vs. Autologous PRP for the Treatment of Hip Osteoarthritis. J Clin Med. 2022;11(15):4505.","journal-title":"J Clin Med."},{"key":"1378_CR100","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/JPR.S347961","volume":"15","author":"S Luan","year":"2022","unstructured":"Luan S, Wang S, Lin C, Fan S, Liu C, Ma C, et al. Comparisons of Ultrasound-Guided Platelet-Rich Plasma Intra-Articular Injection and Extracorporeal Shock Wave Therapy in Treating ARCO I-III Symptomatic Non-Traumatic Femoral Head Necrosis: A Randomized Controlled Clinical Trial. J Pain Res. 2022;15:341\u201354.","journal-title":"J Pain Res"},{"issue":"12","key":"1378_CR101","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.arthro.2013.09.006","volume":"29","author":"A Khoshbin","year":"2013","unstructured":"Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013;29(12):2037\u201348.","journal-title":"Arthroscopy"},{"issue":"5","key":"1378_CR102","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076\u201384.","journal-title":"J Cell Biochem."},{"issue":"5","key":"1378_CR103","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant. 2016;25(5):829\u201348.","journal-title":"Cell Transplant"},{"issue":"9","key":"1378_CR104","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/term.2914","volume":"13","author":"C Brown","year":"2019","unstructured":"Brown C, McKee C, Bakshi S, Walker K, Hakman E, Halassy S, et al. Mesenchymal stem cells: Cell therapy and regeneration potential. J Tissue Eng Regen Med. 2019;13(9):1738\u201355.","journal-title":"J Tissue Eng Regen Med"},{"issue":"4","key":"1378_CR105","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/jcp.24223","volume":"228","author":"L Moroni","year":"2013","unstructured":"Moroni L, Fornasari PM. Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues. J Cell Physiol. 2013;228(4):680\u20137.","journal-title":"J Cell Physiol."},{"issue":"2","key":"1378_CR106","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcyt.2014.12.008","volume":"17","author":"J Galipeau","year":"2015","unstructured":"Galipeau J, Krampera M. The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria. Cytotherapy. 2015;17(2):125\u20137.","journal-title":"Cytotherapy"},{"issue":"5\u20136","key":"1378_CR107","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","volume":"20","author":"L da Silva","year":"2009","unstructured":"da Silva L, Meirelles AM, Fontes DT, Covas AI, Caplan,. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5\u20136):419\u201327.","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"1378_CR108","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1152\/ajpheart.00186.2009","volume":"296","author":"A Shabbir","year":"2009","unstructured":"Shabbir A, Zisa D, Suzuki G, Lee T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol. 2009;296(6):888\u201397.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"2","key":"1378_CR109","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jhps\/hnx011","volume":"4","author":"R Mardones","year":"2017","unstructured":"Mardones R, Jofr\u00e9 CM, Tobar L, Minguell JJ. Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. J Hip Preserv Surg. 2017;4(2):159\u201363.","journal-title":"J Hip Preserv Surg."},{"issue":"1","key":"1378_CR110","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13287-020-01810-8","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Ma Y, Guangtao Fu, Zhang R, Li Q, Deng Z, et al. 10-year follow-up results of the prospective, double-blinded, randomized, controlled study on autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of the femoral head. Stem Cell Res Ther. 2020;11(1):287.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"1378_CR111","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2217\/rme-2021-0001","volume":"16","author":"R Burnham","year":"2021","unstructured":"Burnham R, Smith A, Hart D. The safety and effectiveness of bone marrow concentrate injection for knee and hip osteoarthritis: a Canadian cohort. Regen Med. 2021;16(7):619\u201328.","journal-title":"Regen Med"},{"issue":"6","key":"1378_CR112","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00264-022-05611-x","volume":"47","author":"S Natali","year":"2023","unstructured":"Natali S, Screpis D, Romeo M, Magnanelli S, Rovere G, Andrea A, et al. Is intra-articular injection of autologous micro -fragmented adipose tissue effective in hip osteoarthritis? A three year follow-up. Int Orthop. 2023;47(6):1487\u201392.","journal-title":"Int Orthop."},{"issue":"1","key":"1378_CR113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11916-023-01191-6","volume":"28","author":"M Ehioghae","year":"2024","unstructured":"Ehioghae M, Vippa TK, Askins D, Slusarczyk S, Bobo E, Montoya A, et al. Exploring orthopedic stem-cell approaches for osteoarthritis management: current trends and future horizons. Curr Pain Headache Rep. 2024;28(1):27\u201335.","journal-title":"Curr Pain Headache Rep."},{"issue":"6","key":"1378_CR114","first-page":"336","volume":"18","author":"M Emadedin","year":"2015","unstructured":"Emadedin M, Liastani MG, Fazeli R, Mohseni F, Moghadasali R, Mardpour S, et al. Long-term follow-up of intra-articular injection of autologous mesenchymal stem cells in patients with knee, ankle, or hip osteoarthritis. Arch Iran Med. 2015;18(6):336\u201344.","journal-title":"Arch Iran Med."},{"key":"1378_CR115","doi-asserted-by":"publisher","first-page":"117954761879157","DOI":"10.1177\/1179547618791574","volume":"11","author":"M Darrow","year":"2018","unstructured":"Darrow M, Shaw B, Darrow B, Wisz S. Short-term outcomes of treatment of hip osteoarthritis with 4 bone marrow concentrate injections: a case series. Clin Med Insights Case Rep. 2018;11:1179547618791574.","journal-title":"Clin Med Insights Case Rep"},{"key":"1378_CR116","first-page":"75","volume":"90","author":"C Dall'Oca","year":"2019","unstructured":"Dall\u2019Oca C, Breda S, Elena N, Valentini R, Samaila EM, Magnan B. Mesenchymal Stem Cells injection in hip osteoarthritis: preliminary results. Acta Biomed. 2019;90:75\u201380.","journal-title":"Acta Biomed."},{"key":"1378_CR117","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.reth.2023.06.006","volume":"24","author":"Y Onoi","year":"2023","unstructured":"Onoi Y, Matsumoto T, Sobajima S, Tsubosaka M, Hayashi S, Matsushita T, et al. Clinical use of autologous adipose-derived stromal vascular fraction cell injections for hip osteoarthritis. Regen Ther. 2023;24:94\u2013102.","journal-title":"Regen Ther"},{"issue":"1","key":"1378_CR118","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcyt.2018.11.003","volume":"21","author":"SK Soltani","year":"2019","unstructured":"Soltani SK, Forogh B, Ahmadbeigi N, Kharazi HH, Fallahzadeh K, Kashani L, et al. Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study. Cytotherapy. 2019;21(1):54\u201363.","journal-title":"Cytotherapy."},{"issue":"2","key":"1378_CR119","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/asj\/sjv135","volume":"36","author":"PB Fodor","year":"2016","unstructured":"Fodor PB, Paulseth SG. Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet Surg J. 2016;36(2):229\u201336.","journal-title":"Aesthet Surg J."},{"issue":"12","key":"1378_CR120","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1177\/0363546517716641","volume":"45","author":"CH Jo","year":"2017","unstructured":"Jo CH, Chai JW, Jeong EC, Oh S, Shin JS, Shim H, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am J Sports Med. 2017;45(12):2774\u201383.","journal-title":"Am J Sports Med."},{"issue":"7\u20138","key":"1378_CR121","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2119\/molmed.2010.00157","volume":"17","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med. 2011;17(7\u20138):579\u201387.","journal-title":"Mol Med"},{"issue":"9","key":"1378_CR122","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/sctm.17-0031","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, J\u00f8rgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, S\u00f8rensen JA. Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events. Stem Cells Transl Med. 2017;6(9):1786\u201394.","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"1378_CR123","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/ar3735","volume":"14","author":"M Sato","year":"2012","unstructured":"Sato M, Uchida K, Nakajima H, Miyazaki T, Guerrero AR, Watanabe S, et al. Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis. Arthritis Res Ther. 2012;14(1):R31.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"1378_CR124","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12967-016-0998-2","volume":"14","author":"JM Lamo-Espinosa","year":"2016","unstructured":"Lamo-Espinosa JM, Mora G, Blanco JF, Granero-Molt\u00f3 F, Nu\u00f1ez-C\u00f3rdoba JM, S\u00e1nchez-Echenique C, et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I\/II). J Transl Med. 2016;14(1):246.","journal-title":"J Transl Med."},{"issue":"10","key":"1378_CR125","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/term.1565","volume":"8","author":"P Pires","year":"2014","unstructured":"Pires P, de Carvalho KM, Hamel RD, King AGS, Haque M, Dietrich MA, et al. Comparison of infrapatellar and subcutaneous adipose tissue stromal vascular fraction and stromal\/stem cells in osteoarthritic subjects. J Tissue Eng Regen Med. 2014;8(10):757\u201362.","journal-title":"J Tissue Eng Regen Med."},{"issue":"5","key":"1378_CR126","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1182\/blood-2009-05-219923","volume":"115","author":"J Han","year":"2010","unstructured":"Han J, Koh YJ, Moon HR, Ryoo HG, Cho CH, Kim I, et al. Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. Blood. 2010;115(5):957\u201364.","journal-title":"Blood."},{"issue":"5","key":"1378_CR127","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1634\/stemcells.2005-0235","volume":"24","author":"K McIntosh","year":"2006","unstructured":"McIntosh K, Zvonic S, Garrett S, Mitchell JB, Elizabeth ZF, Hammill L, et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells. 2006;24(5):1246\u201353.","journal-title":"Stem Cells."},{"issue":"1","key":"1378_CR128","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13287-017-0598-y","volume":"8","author":"P Bora","year":"2017","unstructured":"Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017;8(1):145.","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"1378_CR129","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/0363546514554190","volume":"43","author":"YS Kim","year":"2015","unstructured":"Kim YS, Choi YJ, Suh DS, Heo DB, Kim Y Il, Ryu JS, et al. Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold? Am J Sports Med. 2015;43(1):176\u201385.","journal-title":"Am J Sports Med."},{"issue":"5","key":"1378_CR130","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.arthro.2016.01.020","volume":"32","author":"YS Kim","year":"2016","unstructured":"Kim YS, Koh YG. Injection of mesenchymal stem cells as a supplementary strategy of marrow stimulation improves cartilage regeneration after lateral sliding calcaneal osteotomy for varus ankle osteoarthritis: clinical and second-look arthroscopic results. Arthroscopy. 2016;32(5):878\u201389.","journal-title":"Arthroscopy."},{"issue":"11","key":"1378_CR131","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1177\/0363546515599632","volume":"43","author":"YS Kim","year":"2015","unstructured":"Kim YS, Kwon OR, Choi YJ, Suh DS, Heo DB, Koh YG. Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am J Sports Med. 2015;43(11):2738\u201346.","journal-title":"Am J Sports Med."},{"issue":"6","key":"1378_CR132","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.knee.2012.04.001","volume":"19","author":"YG Koh","year":"2012","unstructured":"Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902\u20137.","journal-title":"Knee"},{"issue":"11","key":"1378_CR133","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.arthro.2014.05.036","volume":"30","author":"Y-G Koh","year":"2014","unstructured":"Koh Y-G, Kwon O-R, Kim Y-S, Choi Y-J. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy. 2014;30(11):1453\u201360.","journal-title":"Arthroscopy"},{"issue":"5","key":"1378_CR134","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s00167-013-2807-2","volume":"23","author":"Y-G Koh","year":"2015","unstructured":"Koh Y-G, Choi Y-J, Kwon S-K, Kim Y-S, Yeo J-E. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015;23(5):1308\u201316.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"1","key":"1378_CR135","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.arthro.2015.09.010","volume":"32","author":"Y-G Koh","year":"2016","unstructured":"Koh Y-G, Kwon O-R, Kim Y-S, Choi Y-J, Tak D-H. Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthroscopy. 2016;32(1):97\u2013109.","journal-title":"Arthroscopy"},{"issue":"7","key":"1378_CR136","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1177\/0363546514529641","volume":"42","author":"YG Koh","year":"2014","unstructured":"Koh YG, Choi YJ, Kwon OR, Kim YS. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am J Sports Med. 2014;42(7):1628\u201337.","journal-title":"Am J Sports Med."},{"issue":"10","key":"1378_CR137","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/01.CIR.0000121425.42966.F1","volume":"109","author":"J Rehman","year":"2004","unstructured":"Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and anti-apoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1291\u20138.","journal-title":"Circulation"},{"issue":"14","key":"1378_CR138","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1089\/scd.2011.0722","volume":"21","author":"M Strioga","year":"2012","unstructured":"Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012;21(14):2724\u201352.","journal-title":"Stem Cells Dev"},{"issue":"4","key":"1378_CR139","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5966\/sctm.2014-0161","volume":"4","author":"D You","year":"2015","unstructured":"You D, Jang MJ, Kim BH, Song G, Lee C, Suh N, et al. Comparative study of autologous stromal vascular fraction and adipose-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. Stem Cells Transl Med. 2015;4(4):351\u20138.","journal-title":"Stem Cells Transl Med."},{"issue":"5","key":"1378_CR140","doi-asserted-by":"publisher","first-page":"e0156161","DOI":"10.1371\/journal.pone.0156161","volume":"11","author":"S Domergue","year":"2016","unstructured":"Domergue S, Bony C, Maumus M, Toupet K, Frouin E, Rigau V, et al. Comparison between stromal vascular fraction and adipose mesenchymal stem cells in remodeling hypertrophic scars. PLoS ONE. 2016;11(5):e0156161.","journal-title":"PLoS ONE"},{"issue":"6","key":"1378_CR141","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/wrr.12665","volume":"26","author":"M Shimizu","year":"2018","unstructured":"Shimizu M, Matsumine H, Osaki H, Ueta Y, Tsunoda S, Kamei W, et al. Adiposederived stem cells and the stromal vascular fraction in polyglycolic acidcollagen nerve conduits promote rat facial nerve regeneration. Wound Repair Regen. 2018;26(6):446\u201355.","journal-title":"Wound Repair Regen"},{"issue":"4","key":"1378_CR142","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/00913847.2020.1758001","volume":"48","author":"A Biazzo","year":"2020","unstructured":"Biazzo A, D\u2019Ambrosi R, Masia F, Izzo V, Verde F. Autologous adipose stem cell therapy for knee osteoarthritis: where are we now? Phys Sportsmed. 2020;48(4):392\u20139.","journal-title":"Phys Sportsmed"},{"issue":"5","key":"1378_CR143","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00264-018-4099-0","volume":"43","author":"Z Hong","year":"2019","unstructured":"Hong Z, Chen J, Zhang S, Zhao C, Bi M, Chen X, et al. Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop. 2019;43(5):1123\u201334.","journal-title":"Int Orthop"},{"key":"1378_CR144","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.reth.2017.04.002","volume":"6","author":"N Yokota","year":"2017","unstructured":"Yokota N, Yamakawa M, Shirata T, Kimura T, Kaneshima H. Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee. Regen Ther. 2017;6:108\u201312.","journal-title":"Regen Ther"},{"issue":"11","key":"1378_CR145","doi-asserted-by":"publisher","first-page":"747","DOI":"10.14740\/jocmr4354","volume":"12","author":"B Mehling","year":"2020","unstructured":"Mehling B, Hric M, Salatkova A, Vetrak R, Santora D, Ovariova M, et al. A retrospective study of stromal vascular fraction cell therapy for osteoarthritis. J Clin Med Res. 2020;12(11):747\u201351.","journal-title":"J Clin Med Res"},{"issue":"4","key":"1378_CR146","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.arthro.2012.11.017","volume":"29","author":"Y-G Koh","year":"2013","unstructured":"Koh Y-G, Jo S-B, Kwon O-R, Suh D-S, Lee S-W, Park S-H, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy. 2013;29(4):748\u201355.","journal-title":"Arthroscopy"},{"issue":"7","key":"1378_CR147","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrrheum.2013.44","volume":"9","author":"X Chevalier","year":"2013","unstructured":"Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol. 2013;9(7):400\u201310.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1378_CR148","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1054\/jocn.2000.0684","volume":"7","author":"N Mahant","year":"2000","unstructured":"Mahant N, Clouston PD, Lorentz IT. The current use of botulinum toxin. J Clin Neurosci. 2000;7(5):389\u201394.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1378_CR149","first-page":"50","volume":"25","author":"L Wang","year":"2009","unstructured":"Wang L, Tai N-Z, Fan Z-H. Effect of botulinum toxin type A on the expression of substance P, calcitonin gene-related peptide, transforming growth factor beta-1 and alpha smooth muscle actin A in wound healing in rats. Zhonghua Zheng Xing Wai Ke Za Zhi. 2009;25(1):50\u20133.","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"issue":"1","key":"1378_CR150","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1213\/ANE.0b013e3181ffa1d7","volume":"112","author":"WH Lee","year":"2011","unstructured":"Lee WH, Shin TJ, Kim HJ, Lee JK, Suh HW, Lee SC, et al. Intrathecal administration of botulinum neurotoxin type A attenuates formalin-induced nociceptive responses in mice. Anesth Analg. 2011;112(1):228\u201335.","journal-title":"Anesth Analg."},{"issue":"Pt B","key":"1378_CR151","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.expneurol.2016.05.029","volume":"285","author":"A Coelho","year":"2016","unstructured":"Coelho A, Oliveira R, Cruz F, Cruz CD. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats. Exp Neurol. 2016;285(Pt B):159\u201366.","journal-title":"Exp Neurol."},{"issue":"4","key":"1378_CR152","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/AJP.0000000000000538","volume":"34","author":"M Courseau","year":"2018","unstructured":"Courseau M, Salle PV, Ranoux D, de Pouilly LA. Efficacy of Intra-Articular Botulinum Toxin in Osteoarticular Joint Pain: A Meta-Analysis of Randomized Controlled Trials. Clin J Pain. 2018;34(4):383\u20139.","journal-title":"Clin J Pain."},{"issue":"6","key":"1378_CR153","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2340\/16501977-2340","volume":"50","author":"X Bao","year":"2018","unstructured":"Bao X, Tan J-W, Flyzik M, Ma X-C, Liu H, Liu H-Y. Effect of therapeutic exercise on knee osteoarthritis after intra-articular injection of botulinum toxin type A, hyaluronate or saline: a randomized controlled trial. J Rehabil Med. 2018;50(6):534\u201341.","journal-title":"J Rehabil Med"},{"issue":"10","key":"1378_CR154","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1097\/j.pain.0000000000001625","volume":"160","author":"M Schmelz","year":"2019","unstructured":"Schmelz M, Mantyh P, Malfait A-M, Farrar J, Yaksh T, Tive L, et al. Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety. Pain. 2019;160(10):2210\u201320.","journal-title":"Pain"},{"issue":"3","key":"1378_CR155","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/jcp.25936","volume":"233","author":"YW Su","year":"2018","unstructured":"Su YW, Zhou XF, Foster BK, Grills BL, Xu J, Xian CJ. Roles of neurotrophins in skeletal tissue formation and healing. J Cell Physiol. 2018;233(3):2133\u201345.","journal-title":"J Cell Physiol."},{"issue":"2","key":"1378_CR156","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/pm\/pnw262","volume":"18","author":"J Chen","year":"2017","unstructured":"Chen J, Li J, Li R, Wang H, Yang J, Jichun Xu, et al. Efficacy and safety of tanezumab on osteoarthritis knee and hip pains: a meta-analysis of randomized controlled trials. Pain Med. 2017;18(2):374\u201385.","journal-title":"Pain Med"},{"issue":"Suppl 1","key":"1378_CR157","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.joca.2014.10.003","volume":"23","author":"TJ Schnitzer","year":"2015","unstructured":"Schnitzer TJ, Marks JA. A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee. Osteoarthritis Cartilage. 2015;23(Suppl 1):S8-17.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"1378_CR158","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2019.8044","volume":"322","author":"TJ Schnitzer","year":"2019","unstructured":"Schnitzer TJ, Easton R, Pang S, Levinson DJ, Pixton G, Viktrup L, et al. Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial. JAMA. 2019;322(1):37\u201348.","journal-title":"JAMA."},{"issue":"6","key":"1378_CR159","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/annrheumdis-2019-216296","volume":"79","author":"F Berenbaum","year":"2020","unstructured":"Berenbaum F, Blanco FJ, Guermazi A, Miki K, Yamabe T, Viktrup L, et al. Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period. Ann Rheum Dis. 2020;79(6):800\u201310.","journal-title":"Ann Rheum Dis."},{"issue":"7","key":"1378_CR160","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/art.41674","volume":"73","author":"MC Hochberg","year":"2021","unstructured":"Hochberg MC, Carrino JA, Schnitzer TJ, Guermazi A, Walsh DA, White A, et al. Long-term safety and efficacy of subcutaneous tanezumab versus nonsteroidal antiinflammatory drugs for hip or knee osteoarthritis: a randomized trial. Arthritis Rheumatol. 2021;73(7):1167\u201377.","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"1378_CR161","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0049-0172(96)80036-9","volume":"25","author":"CI Westacott","year":"1996","unstructured":"Westacott CI, Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum. 1996;25(4):254\u201372.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"1378_CR162","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00296-014-3016-0","volume":"34","author":"AP Sim\u00e3o","year":"2014","unstructured":"Sim\u00e3o AP, de Oliveira Almeida TM, Mendon\u00e7a VA, Santos SA, Gomes WF, Coimbra CC, et al. Soluble TNF receptors are produced at sites of inflammation and are inversely associated with self-reported symptoms (WOMAC) in knee osteoarthritis. Rheumatol Int. 2014;34(12):1759\u201363.","journal-title":"Rheumatol Int."},{"issue":"5","key":"1378_CR163","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3349\/ymj.2015.56.5.1379","volume":"56","author":"S Ohtori","year":"2015","unstructured":"Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, et al. Efficacy of direct injection of etanercept into knee joints for pain in moderate and severe knee osteoarthritis. Yonsei Med J. 2015;56(5):1379\u201383.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1378_CR164","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/BOR.0000000000000350","volume":"29","author":"WM Oo","year":"2017","unstructured":"Oo WM, Linklater JM, Hunter DJ. Imaging in knee osteoarthritis. Curr Opin Rheumatol. 2017;29(1):86\u201395.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1378_CR165","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.joca.2019.08.005","volume":"28","author":"FW Roemer","year":"2020","unstructured":"Roemer FW, Collins J, Kwoh CK, Hannon MJ, Neogi T, Felson DT, et al. MRI-based screening for structural definition of eligibility in clinical DMOAD trials: rapid osteoarthritis MRI eligibility score (ROAMES). Osteoarthritis Cartilage. 2020;28(1):71\u201381.","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"1378_CR166","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00330-017-5186-0","volume":"28","author":"G Ferrero","year":"2018","unstructured":"Ferrero G, Sconfienza LM, Fiz F, Fabbro E, Corazza A, Dettore D, et al. Effect of intra-articular injection of intermediate-weight hyaluronic acid on hip and knee cartilage: in-vivo evaluation using T2 mapping. Eur Radiol. 2018;28(6):2345\u201355.","journal-title":"Eur Radiol."},{"issue":"1","key":"1378_CR167","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12891-021-04672-0","volume":"22","author":"DM Long","year":"2021","unstructured":"Long DM, Fitzpatrick J. Safety and efficacy of a single intra-articular injection of hyaluronic acid in osteoarthritis of the hip: a case series of 87 patients. BMC Musculoskelet Disord. 2021;22(1):797.","journal-title":"BMC Musculoskelet Disord."},{"issue":"5","key":"1378_CR168","first-page":"857","volume":"34","author":"S Bisicchia","year":"2016","unstructured":"Bisicchia S, Bernardi G, Tudisco C. HYADD 4 versus methylprednisolone acetate in symptomatic knee osteoarthritis: a single-centre single blind prospective randomised controlled clinical study with 1-year follow-up. Clin Exp Rheumatol. 2016;34(5):857\u201363.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"1378_CR169","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1177\/03635465221095563","volume":"51","author":"A Lim","year":"2023","unstructured":"Lim A, Zhu JB, Khanduja V. The Use of Intra-articular Platelet-Rich Plasma as a Therapeutic Intervention for Hip Osteoarthritis: A Systematic Review and Meta-analysis. Am J Sports Med. 2023;51(9):2487\u201397.","journal-title":"Am J Sports Med."},{"issue":"7","key":"1378_CR170","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1302\/2046-3758.107.BJR-2020-0418.R1","volume":"10","author":"S Zhu","year":"2021","unstructured":"Zhu S, Zhang X, Chen Xi, Wang Y, Li S, Qian W. Comparison of cell therapy and other novel adjunctive therapies combined with core decompression for the treatment of osteonecrosis of the femoral head\u202f: a systematic review and meta-analysis of 20 studies. Bone Joint Res. 2021;10(7):445\u201358.","journal-title":"Bone Joint Res"},{"issue":"4","key":"1378_CR171","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.joca.2022.11.005","volume":"31","author":"MJ Richard","year":"2023","unstructured":"Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthritis Cartilage. 2023;31(4):458\u201366.","journal-title":"Osteoarthritis Cartilage"},{"key":"1378_CR172","first-page":"155633162412590","volume":"7","author":"OF Perez","year":"2024","unstructured":"Perez OF, Warburton C, Philippon Jr MC, Philippon MJ, Best TM. The Efficacy of Bone Marrow Stem Cell Therapy in Hip Osteoarthritis: A Scoping Review. HSS J. 2024;7:15563316241259036.","journal-title":"HSS J."}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01378-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-025-01378-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01378-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:03:49Z","timestamp":1771275829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-025-01378-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":172,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1378"],"URL":"https:\/\/doi.org\/10.1007\/s11916-025-01378-z","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"5 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"64"}}